Palavras-chave
Como Citar
Resumo
Trata-se de uma revisão de literatura científica com pesquisas efetuada nas bases de dados Google Scholar e Pubmed com o objetivo de relatar o impacto da microbiota intestinal para o paciente hospitalizado, envolvendo outros microrganismos exógenos que afetam a saúde da microbiota intestinal e o processo de saúde-doença no organismo humano. A microbiota do trato gastrointestinal, com constituição diversa e rica em bactérias comensais, apresenta grande relação com o desenvolvimento e instalação de diversos patógenos no paciente, representando um material de imensa importância por sua ligação com diversos sistemas, como respiratório e imunológico. O ambiente hospitalar é apontado como potencial para a disseminação de infecções, situação associada à assistência em saúde, a terapia com antibióticos, processos invasivos e a condição do paciente. Conclui-se que a relação entre microbiota intestinal instável e o paciente hospitalizado configurando-se como uma problemática para o bem estar do indivíduo, esperamos que a compreensão sobre a conexão e a necessidade de uma microbiota intestinal equilibrada para o estabelecimento da homeostase do ser humano por completo, permita que esses microrganismos sejam protegidos com mais vigor por meio de tratamentos mais cuidadosos.
Referências
ADELMAN, Max W.; WOODWORTH, Michael H.; LANGELIER, Charles; BUSCH, Lindsay M.; KEMPKER, Jordan A.; KRAFT, Colleen S.; MARTIN, Greg S. The gut microbiome’s role in the development, maintenance, and outcomes of sepsis. Critical Care, [s. l.], v. 24, n. 1, p. 278, 2020. DOI: https://doi.org/10.1186/s13054-020-02989-1.
AGUDELO-OCHOA, Gloria M.; VALDÉS-DUQUE, Beatriz E.; GIRALDO-GIRALDO, Nubia A.; JAILLIER-RAMÍREZ, Ana M.; GIRALDO-VILLA, Adriana; ACEVEDO-CASTAÑO, Irene; YEPES-MOLINA, Mónica A.; BARBOSA-BARBOSA, Janeth; BENÍTEZ-PAÉZ, Alfonso. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis. Gut Microbes, [s.l.], v. 12, n. 1, p. 1707610, 10 jan. 2020. DOI: http://dx.doi.org/10.1080/19490976.2019.1707610.
BADI, Sara Ahmadi; TARASHI, Samira; FATEH, Abolfazl; ROHANI, Pejman; MASOTTI, Andrea; SIADAT, Seyed Davar. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis. Mediators Of Inflammation, [S.L.], v. 2021, p. 1-12, 16 abr. 2021. Hindawi Limited. DOI: http://dx.doi.org/10.1155/2021/6611222.
CROBACH, Monique J. T.; DUCARMON, Quinten R.; TERVEER, Elisabeth M.; HARMANUS, Celine; SANDERS, Ingrid M. J. G.; VERDUIN, Kees M.; KUIJPER, Ed J.; ZWITTINK, Romy D.. The Bacterial Gut Microbiota of Adult Patients Infected, Colonized or Noncolonized by Clostridioides difficile. Microorganisms, [S.L.], v. 8, n. 5, p. 677, 6 maio 2020. MDPI AG. DOI: http://dx.doi.org/10.3390/microorganisms8050677.
CUI, Meng-Yan; CUI, Zhen-Yu; ZHAO, Meng-Qi; ZHANG, Meng-Jie; JIANG, Qiao-Li; WANG, Jing-Jing; LU, Lun-Gen; LU, Ying-Ying. The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota. BMC Microbiology, [s. l.], v. 22, n. 1, p. 321, 2022. DOI: https://doi.org/10.1186/s12866-022-02732-6.
CZEPIEL, Jacek; DRÓŜDŜ, Mirosław; PITUCH, Hanna; KUIJPER, Ed J.; PERUCKI, William; MIELIMONKA, Aleksandra; GOLDMAN, Sarah; WULTAńSKA, Dorota; GARLICKI, Aleksander; BIESIADA, Grażyna. Clostridium difficile infection: review. European Journal Of Clinical Microbiology & Infectious Diseases, [S.L.], v. 38, n. 7, p. 1211-1221, 3 abr. 2019. Springer Science and Business Media LLC. DOI: http://dx.doi.org/10.1007/s10096-019-03539-6.
GARCIA, Elisa Rubio; VERGARA, Andrea; AZIZ, Fátima; NARVÁEZ, Sofía; CUESTA, Genoveva; HERNÁNDEZ, María; TOAPANTA, David; MARCO, Francesc; FERNÁNDEZ, Javier; SORIANO, Alex. Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients. Clinical Microbiology And Infection, [S.L.], v. 28, n. 7, p. 975-982, jul. 2022. Elsevier BV. DOI: http://dx.doi.org/10.1016/j.cmi.2022.01.004.
GOMAA, Eman Zakaria. Human gut microbiota/microbiome in health and diseases: a review. Antonie van Leeuwenhoek, [s.l.], v. 113, n. 12, p. 2019-2040, 2 nov. 2020. Springer Science and Business Media LLC. DOI: http://dx.doi.org/10.1007/s10482-020-01474-7.
HAAK, Bastiaan W.; PRESCOTT, Hallie C.; WIERSINGA, W. Joost. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis. Frontiers in Immunology, [s. l.], v. 9, p. 2042, 2018. DOI: 10.3389/fimmu.2018.02042
HERNÁNDEZ, Marta; DE FRUTOS, Mónica; RODRÍGUEZ-LÁZARO, David; LÓPEZ-URRUTIA, Luis; QUIJADA, Narciso M.; EIROS, Jose M. Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea. Frontiers in Microbiology, [s. l.], v. 9, p. 3331, 2019.
DOI: https://doi.org/10.3389/fmicb.2018.03331
HOLSCHER, Hannah D. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes, [s. l.], v. 8, n. 2, p. 172–184, 2017. DOI: https://doi.org/10.1080/19490976.2017.1290756.
KERSCHNER, Heidrun; CABAL, Adriana; HARTL, Rainer.; MACHHERNDL-SPANDL, Sigrid; ALLERBERGER, Franz; RUPPITSCH, Werner; APFALTER, Petra. Hospital outbreak caused by linezolid resistant Enterococcus faecium in Upper Austria. Antimicrobial Resistance & Infection Control, [s. l.], v. 8, n. 1, p. 150, 2019. DOI: https://doi.org/10.1186/s13756-019-0598-z.
LAFATA, Giorgio; WEBER, Peter; MOHAJERI, M. Hasan. Probiotics and the Gut Immune System: indirect regulation. Probiotics And Antimicrobial Proteins, [s.l.], v. 10, n. 1, p. 11-21, 31 ago. 2017. Springer Science and Business Media LLC. DOI: http://dx.doi.org/10.1007/s12602-017-9322-6.
LEVAST, Benoit; BENECH, Nicolas; GASC, Cyrielle; BATAILLER, Cécile; SENNEVILLE, Eric; LUSTIG, Sébastien; POUDEROUX, Cécile; BOUTOILLE, David; BOUCINHA, Lilia; DAUCHY, Frederic-Antoine; ZELLER, Valérie; MAYNARD, Marianne; CAZANAVE, Charles; LE THI, Thanh-Thuy; JOSSE, Jérôme; DORÉ, Joel; LAURENT, Frederic; FERRY, Tristan. Impact on the Gut Microbiota of Intensive and Prolonged Antimicrobial Therapy in Patients With Bone and Joint Infection. Frontiers in Medicine, [s. l.], v. 8, p. 586875, 2021. DOI: https://doi.org/10.3389/fmed.2021.586875.
LI, Shaoshuai; ZHOU, Yang; YAN, Dongmei; WAN, Yanmin. An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota. Viruses, [S.L.], v. 14, n. 8, p. 1774, 15 ago. 2022. MDPI AG. DOI: http://dx.doi.org/10.3390/v14081774.
LIU, Qin; MAK, Joyce W. Y.; SU, Qi; YEOH, Y. Kit; LUI, Grace C.-Y.; NG, Shan S. S.; ZHANG, Fen; LI, Amy Y. L.; LU, Wenqi; HUI, David S.-C.; CHAN, Paul K.; CHAN, Francis K. L.; NG, Siew C. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut, [s. l.], v. 71, n. 3, p. 544–552, 2022.
DOI: http://dx.doi.org/10.1136/gutjnl-2021-325989
MAEDA, Yuichi; MOTOOKA, Daisuke; KAWASAKI, Takahiro; OKI, Hiroya; NODA, Yoshimi; ADACHI, Yuichi; NIITSU, Takayuki; OKAMOTO, Shota; TANAKA, Kentaro; FUKUSHIMA, Kiyoharu; AMIYA, Saori; HARA, Reina; OGURO-IGASHIRA, Eri; MATSUKI, Takanori; HIRATA, Haruhiko; TAKEDA, Yoshito; KIDA, Hiroshi; KUMANOGOH, Atsushi; NAKAMURA, Shota; TAKEDA, Kiyoshi. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity. BMC Infectious Diseases, [s. l.], v. 22, n. 1, p. 572, 2022.
DOI: https://doi.org/10.1186/s12879-022-07358-7.
MUSTANSIR DAWOODBHOY, Fatema; PATEL, Bharati K.; PATEL, Kadamb; BHATIA, Madhav; LEE, Chuen N.; MOOCHHALA, Shabbir M. Gut Microbiota Dysbiosis as a Target for Improved Post-Surgical Outcomes and Improved Patient Care: A Review of Current Literature. Shock, [s. l.], v. 55, n. 4, p. 441–454, 2021. DOI: 10.1097/SHK.0000000000001654
NAVIDINIA, Masoumeh; GOUDARZI, Mehdi. Overview Perspective of Bacterial Strategies of Resistance to Biocides and Antibiotics. Archives of Clinical Infectious Diseases, [s. l.], v. In Press, n. In Press, 2019. Disponível em: https://brieflands.com/articles/archcid-65744.html. DOI: https://doi.org/10.5812/archcid.65744.
NEGRUT, Nicoleta; BUNGAU, Simona; BEHL, Tapan; KHAN, Shamim Ahmad; VESA, Cosmin Mihai; BUSTEA, Cristiana; NISTOR-CSEPPENTO, Delia Carmen; RUS, Marius; PAVEL, Flavia-Maria; TIT, Delia Mirela. Risk Factors Associated with Recurrent Clostridioides difficile Infection. Healthcare, [S.L.], v. 8, n. 3, p. 352, 21 set. 2020. MDPI AG. DOI: http://dx.doi.org/10.3390/healthcare8030352.
NG, Siew C; A KAMM, Michael; YEOH, Yun Kit; CHAN, Paul K s; ZUO, Tao; TANG, Whitney; SOOD, Ajit; ANDOH, Akira; OHMIYA, Naoki; ZHOU, Yongjian. Scientific frontiers in faecal microbiota transplantation: joint document of asia-pacific association of gastroenterology (apage) and asia-pacific society for digestive endoscopy (apsde). Gut, [S.L.], v. 69, n. 1, p. 83-91, 14 out. 2019. BMJ. DOI: http://dx.doi.org/10.1136/gutjnl-2019-319407.
OLIPHANT, Kaitlyn; ALLEN-VERCOE, Emma. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome, [s. l.], v. 7, n. 1, p. 91, 2019. DOI:https://doi.org/10.1186/s40168-019-0704-8 .
PILMIS, Benoit; MONNIER, Alban Le; ZAHAR, Jean-Ralph. Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: a narrative review. Microorganisms, [S.L.], v. 8, n. 2, p. 269, 17 fev. 2020. MDPI AG. DOI: http://dx.doi.org/10.3390/microorganisms8020269.
PRISMA. Transparent Reporting of Systematic Reviews and Meta-Analyses. 2023. Disponível em: http://www.prisma-statement.org/Default.aspx.
PORTINCASA, Piero; BONFRATE, Leonilde; VACCA, Mirco; ANGELIS, Maria de; FARELLA, Ilaria; LANZA, Elisa; KHALIL, Mohamad; WANG, David Q.-H.; SPERANDIO, Markus; CIAULA, Agostino di. Gut Microbiota and Short Chain Fatty Acids: implications in glucose homeostasis. International Journal Of Molecular Sciences, [S.L.], v. 23, n. 3, p. 1105, 20 jan. 2022. MDPI AG. DOI:
http://dx.doi.org/10.3390/ijms23031105.
RAMOS, Sónia; SILVA, Vanessa; DAPKEVICIUS, Maria; IGREJAS, Gilberto; POETA, Patrícia. Enterococci, from Harmless Bacteria to a Pathogen. Microorganisms, [S.L.], v. 8, n. 8, p. 1118, 25 jul. 2020. MDPI AG. DOI: http://dx.doi.org/10.3390/microorganisms8081118.
SENDER, Ron; FUCHS, Shai; MILO, Ron. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell, [S.L.], v.164, n.3, p. 337-340, 28 jan. 2016. DOI: https://doi.org/10.1016/j.cell.2016.01.013
SIRANOSIAN, Benjamin A.; BROOKS, Erin F.; ANDERMANN, Tessa; REZVANI, Andrew R.; BANAEI, Niaz; TANG, Hua; BHATT, Ami S. Rare transmission of commensal and pathogenic bacteria in the gut microbiome of hospitalized adults. Nature Communications, [s. l.], v. 13, n. 1, p. 586, 2022. DOI: https://doi.org/10.1038/s41467-022-28048-7.
SCHLECHTE, Jared; ZUCOLOTO, Amanda Z.; YU, Ian-Ling; DOIG, Christopher J.; DUNBAR, Mary J.; MCCOY, Kathy D.; MCDONALD, Braedon. Dysbiosis of a microbiota–immune metasystem in critical illness is associated with nosocomial infections. Nature Medicine, [S.L.], v. 29, n. 4, p. 1017-1027, 9 mar. 2023. Springer Science and Business Media LLC. DOI: http://dx.doi.org/10.1038/s41591-023-02243-5.
SCHMITT, Felix C. F.; BRENNER, Thorsten; UHLE, Florian; LOESCH, Svenja; HACKERT, Thilo; ULRICH, Alexis; HOFER, Stefan; DALPKE, Alexander H.; WEIGAND, Markus A.; BOUTIN, Sébastien. Gut microbiome patterns correlate with higher postoperative complication rates after pancreatic surgery. BMC Microbiology, [s. l.], v. 19, n. 1, p. 42, 2019.
DOI: https://doi.org/10.1186/s12866-019-1399-5
SHAH, Taif; BALOCH, Zulqarnain; SHAH, Zahir; CUI, Xiuming; XIA, Xueshan. The Intestinal Microbiota: impacts of antibiotics therapy, colonization resistance, and diseases. International Journal Of Molecular Sciences, [S.L.], v. 22, n. 12, p. 6597, 20 jun. 2021. DOI: http://dx.doi.org/10.3390/ijms22126597.
SHIN, Jae Hyun; WARREN, Cirle A.. Prevention and treatment of recurrent Clostridioides difficile infection. Current Opinion In Infectious Diseases, [S.L.], v. 32, n. 5, p. 482-489, out. 2019. Ovid Technologies (Wolters Kluwer Health). DOI: http://dx.doi.org/10.1097/qco.0000000000000587.
SONG, Jung Hoon; KIM, You Sun. RecurrentClostridium difficileInfection: risk factors, treatment, and prevention. Gut And Liver, [S.L.], v. 13, n. 1, p. 16-24, 15 jan. 2019. The Editorial Office of Gut and Liver. DOI: http://dx.doi.org/10.5009/gnl18071.
SZYCHOWIAK, Piotr ; VILLAGEOIS-TRAN, Khanh; PATRIER, Juliette; TIMSIT, Jean-François; RUPPÉ, Étienne.The role of the microbiota in the management of intensive care patients. Annals of Intensive Care, [s. l.], v. 12, n. 1, p. 3, 2022. DOI: https://doi.org/10.1186/s13613-021-00976-5.
TAMBURINI, Fiona B.; ANDERMANN, Tessa M.; TKACHENKO, Ekaterina; SENCHYNA, Fiona; BANAEI, Niaz; BHATT, Ami S.. Precision identification of diverse bloodstream pathogens in the gut microbiome. Nature Medicine, [S.L.], v. 24, n. 12, p. 1809-1814, 15 out. 2018. Springer Science and Business Media LLC. DOI: http://dx.doi.org/10.1038/s41591-018-0202-8.
TAN, Glorijoy Shi En; TAY, Hui Lin; TAN, Sock Hoon; LEE, Tau Hong; NG, Tat Ming; LYE, David Chien. Gut Microbiota Modulation: implications for infection control and antimicrobial stewardship. Advances In Therapy, [S.L.], v. 37, n. 10, p. 4054-4067, 7 ago. 2020. Springer Science and Business Media LLC. DOI: http://dx.doi.org/10.1007/s12325-020-01458-z.
VENTERO, María Paz; ESPINOSA, Noelia; JOVER, Rodrigo; GUILLEN, Yolanda; MERINO, Esperanza; RODRÍGUEZ, Juan Carlos. Evolution of intestinal microbiome in a process of faecal microbiota transplantation in a patient with Clostridioides difficile infection: ngs analysis with different bioinformatics software programs. Enfermedades Infecciosas y Microbiologia Clinica (English Ed.), [S.L.], v. 39, n. 4, p. 184-187, abr. 2021. Elsevier BV. DOI: http://dx.doi.org/10.1016/j.eimce.2021.02.001.
XIA, Xiong; NI, Jiangjin; YIN, Shengnan; YANG, Zhipeng; JIANG, Hain; WANG, Chao; PENG, Jeng; WEI, Hongkui; WANG, Xingyu. Elevated Systemic and Intestinal Inflammatory Response Are Associated With Gut Microbiome Disorder After Cardiovascular Surgery. Frontiers in Microbiology, [s. l.], v. 12, p. 686648, 2021. DOI: https://doi.org/10.3389/fmicb.2021.686648.
XUE, Ling; DING, Yinglong; QIN, Qiong; LIU, Linsheng; DING, Xiaoling; ZHOU, Yi; LIU, Kun; SINGLA, Rajeev K.; SHEN, Ke; DIN, Ahmad U.; ZHANG, Yan; SHEN, Zhenya; SHEN, Bairong; MIAO, Liyan. Assessment of the impact of intravenous antibiotics treatment on gut microbiota in patients: Clinical data from pre-and post-cardiac surgery. Frontiers in Cellular and Infection Microbiology, [s. l.], v. 12, p. 1043971, 2023.
DOI: https://doi.org/10.3389/fcimb.2022.1043971.
WANG, Chenyang; LI, Qiurong; REN, Jianan. Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection. Frontiers in Immunology, [s. l.], v. 10, p. 1873, 2019.
DOI: https://doi.org/10.3389/fimmu.2019.01873
WANG, Daosheng; DONG, Danfeng ; WANG, Chen ; CUI, Yingchao ; JIANG, Cen; NI, Qi; SU, Tongxuan; WANG, Guanzheng; MAO, Enqianq; PENG, Yibing. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units. Critical Care, [s. l.], v. 24, n. 1, p. 426, 2020. DOI: https://doi.org/10.1186/s13054-020-03119-7 .
WIEËRS, Grégoire; VERBELEN, Valérie; VAN DEN DRIESSCHE, Mieke; MELNIK, Ekaterina; VANHEULE, Greet; MAROT, Jena-Christophe; CANI, Patrice D. Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing Saccharomyces to a Mixture of Lactobacillus, Bifidobacterium, and Saccharomyces. Frontiers in Public Health, [s. l.], v. 8, p. 578089, 2021.
DOI: https://doi.org/10.3389/fpubh.2020.578089.
WUETHRICH, Irene; W. PELZER, Benedikt; KHODAMORADI, Yascha; VEHRESCHILD, Maria J. G. T. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria. Gut Microbes, [s. l.], v. 13, n. 1, p. 1911279, 2021. DOI: https://doi.org/10.1080/19490976.2021.1911279
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Maria Julia Onofre, Glauber Pimentel Florêncio, Ralciane de Paula Menezes , Denise Von Dolinger de Brito Roder